The impact of influenza vaccination on infection, hospitalisation and mortality in the Netherlands between 2003 and 2015

作者: J.A. Backer , J. Wallinga , A. Meijer , G.A. Donker , W. van der Hoek

DOI: 10.1016/J.EPIDEM.2018.10.001

关键词:

摘要: Influenza epidemics annually cause substantial morbidity and mortality. For this reason, vaccination is offered yearly to persons with an elevated risk for complications. Assessments of the impact are, however, hampered by year-to-year variation in epidemic size vaccine effectiveness. We estimate current programme comparing simulations counterfactual without vaccination. The rely on age- risk-structured transmission model that tracks build-up loss immunity over successive seasons, allows match vary between seasons. parameters are estimated a particle Monte Carlo method approximate Bayesian computation, using epidemiological data effectiveness Netherlands period 11 years. number infections, hospitalisations deaths greatly years because waning may differ every season, which line observed influenza sizes. At overall coverage 21%, has averted average 13% (7.2-19%, 95% range) 24% (16-36%) hospitalisations, 35% (16-50%) deaths. This suggests mainly effective protecting vaccinees from infection rather than reducing transmission. As Dutch population continues grow age, projected (up 2025) gain impact, despite decreasing attack rate.

参考文章(46)
Colin J. Worby, Sandra S. Chaves, Jacco Wallinga, Marc Lipsitch, Lyn Finelli, Edward Goldstein, On the relative role of different age groups in influenza epidemics Epidemics. ,vol. 13, pp. 10- 16 ,(2015) , 10.1016/J.EPIDEM.2015.04.003
Margot A.J.B. Tacken, Birgit Jansen, Jan Mulder, Stephen M. Campbell, Jozé C.C. Braspenning, Dutch influenza vaccination rate drops for fifth consecutive year Vaccine. ,vol. 33, pp. 4886- 4891 ,(2015) , 10.1016/J.VACCINE.2015.07.052
Michael L. Jackson, Lisa A. Jackson, Burney Kieke, David McClure, Manjusha Gaglani, Kempapura Murthy, Ryan Malosh, Arnold Monto, Richard K. Zimmerman, Ivo M. Foppa, Brendan Flannery, Mark G. Thompson, Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons. Vaccine. ,vol. 33, pp. 5181- 5187 ,(2015) , 10.1016/J.VACCINE.2015.07.098
P. Hardelid, R. Pebody, N. Andrews, Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010. Influenza and Other Respiratory Viruses. ,vol. 7, pp. 35- 45 ,(2013) , 10.1111/J.1750-2659.2012.00345.X
J. Donkers, J. Braspenning, J. Mulder, R. Verheij, W. Tiersma, M. Tacken, S. Visscher, Monitoring vaccinatiegraad Nationaal Programma Grieppreventie 2009. LHV. ,(2010)
Derek J Smith, Alan S Lapedes, Jan C De Jong, Theo M Bestebroer, Guus F Rimmelzwaan, Albert DME Osterhaus, Ron AM Fouchier, Mapping the Antigenic and Genetic Evolution of Influenza Virus Science. ,vol. 305, pp. 371- 376 ,(2004) , 10.1126/SCIENCE.1097211
Emilia Vynnycky, Richard Pitman, Ruby Siddiqui, Nigel Gay, W John Edmunds, None, Estimating the impact of childhood influenza vaccination programmes in England and Wales Vaccine. ,vol. 26, pp. 5321- 5330 ,(2008) , 10.1016/J.VACCINE.2008.06.101
E.W. Thommes, A. Chit, G.C. Meier, C.T. Bauch, Examining Ontario's universal influenza immunization program with a multi-strain dynamic model Vaccine. ,vol. 32, pp. 5098- 5117 ,(2014) , 10.1016/J.VACCINE.2014.06.005
Deborah Cromer, Albert Jan Van Hoek, Mark Jit, W John Edmunds, Douglas Fleming, Elizabeth Miller, None, The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. Journal of Infection. ,vol. 68, pp. 363- 371 ,(2014) , 10.1016/J.JINF.2013.11.013
Scott A. McDonald, Anne M. Presanis, Daniela De Angelis, Wim van der Hoek, Mariette Hooiveld, Gé Donker, Mirjam E. Kretzschmar, An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands. Influenza and Other Respiratory Viruses. ,vol. 8, pp. 33- 41 ,(2014) , 10.1111/IRV.12201